[Diabetes, heart, and glitazones].
作者信息
Philippe Jacques
机构信息
Département de Médecine interne, Service d'Endocrinologie, Diabétologie et Nutrition, Hôpital Cantonal, Genève.
出版信息
Rev Med Suisse Romande. 2004 Mar;124(3):133-5.
PMID:15095655
Abstract
摘要
相似文献
1
[Diabetes, heart, and glitazones].
Rev Med Suisse Romande. 2004 Mar;124(3):133-5.
2
Use of glitazones in cardiac patients: a case for B-type natriuretic peptide monitoring?
Am J Cardiol. 2004 Mar 1;93(5):600-2. doi: 10.1016/j.amjcard.2003.11.025.
3
4
Diabetes and heart failure: the role of thiazolidinediones in managing these partners in crime.糖尿病与心力衰竭：噻唑烷二酮类药物在治疗这两种“共犯”中的作用
J Am Coll Cardiol. 2007 Jul 3;50(1):37-9. doi: 10.1016/j.jacc.2007.04.026. Epub 2007 Jun 18.
5
Actos and Avandia in type 2 diabetes. Where do they fit?2型糖尿病中使用的艾可拓和文迪雅。它们的作用如何？
Diabetes Self Manag. 2007 Jul-Aug;24(4):8, 11-3.
6
Clinical inquiries. Do TZDs increase the risk of heart failure for patients with diabetes?
J Fam Pract. 2005 Aug;54(8):723-4.
7
Approach to the management of diabetic patients with heart failure: role of thiazolidinediones.糖尿病合并心力衰竭患者的管理方法：噻唑烷二酮类药物的作用
Am Heart J. 2004 Oct;148(4):551-8. doi: 10.1016/j.ahj.2004.04.033.
8
[Is there a need of glitazones in the treatment of diabetes?].[糖尿病治疗中是否需要格列酮类药物？]
Tidsskr Nor Laegeforen. 2007 Aug 23;127(16):2124; author reply 2124.
9
Rosiglitazone (Avandia) revisited.罗格列酮（文迪雅）再审视。
Med Lett Drugs Ther. 2010 Mar 8;52(1333):17.
10
[The true place of glitazones in the treatment of diabetes: after the PROactive study].[格列酮类药物在糖尿病治疗中的真实地位：PROactive研究之后]
Ugeskr Laeger. 2006 Jun 19;168(25):2477-9; author reply 2479-80.
Zotero 插件